Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064917

SVP & General Counsel acquired 28,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · SVP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-18 Grant or award : show line 1 in the form +28,550 78,900 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-18 Grant or award : show line 2 in the form Stock Option +51,000 51,000 D
Loading xslF345X03/doc4.xml…